Federico A Monzon

Federico A Monzon has extensive work experience in the medical field. Federico A is currently serving as the Chief Medical Officer at Delphi Diagnostics Inc. since April 2023. Prior to this, they held the position of President at Genomic Path starting from June 2020.

From 2011 to 2023, Monzon worked at Baylor College of Medicine in various roles including Adjunct Faculty, Associate Professor, and Director of Molecular Pathology, Cancer Genetics Laboratory.

Federico A also worked as the Chief Medical Officer at Castle Biosciences from November 2015 to May 2020 and as an Oncology Guru at Invitae from September 2013 to October 2015.

Monzon's earlier work experience includes roles such as Associate Professor of Pathology at Weill Cornell Medical College, Director of Research Pathology and Molecular Diagnostics Cores at The Methodist Hospital Research Institute, Director of Molecular Pathology at The Methodist Hospital, and Founder and Head of Scientific Advisory Board at iKaryos Diagnostics, Inc.

Federico A started their career as an Assistant Professor at the University of Pittsburgh School of Medicine from 2003 to 2007.

Federico A Monzon obtained their MD degree in Medicine from the Universidad Nacional Autónoma de México, where they attended from 1986 to 1992. Following that, they pursued a Medical Specialty in Anatomic and Clinical Pathology at Thomas Jefferson University from 1998 to 2002. Later, they were a Clinical Fellow at the University of Pittsburgh for Molecular Genetic Pathology from 2002 to 2003.